Mark Alfenito,Mark Baer,Doris Bucher,Geoffrey Yarranton
申请号：
US15272790
公开号：
US20170035876A1
申请日:
2016.09.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed generally to M1 polypeptides that can be utilized as vaccines and/or antigens for generation of anti-M1 polypeptide antibodies for prophylactic treatment of individuals who are susceptible to infection by influenza virus. The anti-M1 polypeptide antibodies of the invention are useful for treatment of individuals infected with influenza virus, or useful for prophylactic treatment of individuals who are susceptible to infection by influenza virus, or for immune-suppressed individuals who cannot generate an effective antibody response.
